These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1391763)

  • 21. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats.
    Connor HE; Higgins GA
    Eur J Pharmacol; 1990 Jun; 182(1):63-72. PubMed ID: 2144824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat.
    Yoshimoto K; McBride WJ
    Neurochem Res; 1992 May; 17(5):401-7. PubMed ID: 1356241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of 5-hydroxytryptamine (5-HT) from medullary and mesencephalic raphé neurones after grafting to the rat hippocampus: evidence for regulation by 5-HT1A autoreceptors.
    Sharp T; Foster GA
    Neurosci Lett; 1991 Nov; 132(2):179-82. PubMed ID: 1838408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M; Kennett GA; Curzon G
    Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of subcutaneous administration of the chemical algogen formalin, on 5-HT metabolism in the nucleus raphe magnus and the medullary dorsal horn: a voltammetric study in freely moving rats.
    Puig S; Rivot JP; Besson JM
    Brain Res; 1992 Sep; 590(1-2):250-4. PubMed ID: 1422833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT.
    Remy SM; Schreiber R; Dalmus M; De Vry J
    Psychopharmacology (Berl); 1996 May; 125(1):89-91. PubMed ID: 8724453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.
    Johnson RG; Fiorella D; Winter JC; Rabin RA
    Eur J Pharmacol; 1997 Jun; 329(1):99-106. PubMed ID: 9218690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.
    Romero L; Celada P; Artigas F
    Eur J Pharmacol; 1994 Nov; 265(1-2):103-6. PubMed ID: 7883021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of medullary raphe serotonergic neurons has age-dependent effects on the CO2 response in newborn piglets.
    Messier ML; Li A; Nattie EE
    J Appl Physiol (1985); 2004 May; 96(5):1909-19. PubMed ID: 14752121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin.
    Bosker F; Klompmakers A; Westenberg H
    J Neurochem; 1994 Dec; 63(6):2165-71. PubMed ID: 7964736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H; Laubie M; Schmitt H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.
    Bonvento G; Scatton B; Claustre Y; Rouquier L
    Neurosci Lett; 1992 Mar; 137(1):101-4. PubMed ID: 1385646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus.
    Duncan MJ; Grear KE; Hoskins MA
    Brain Res; 2004 May; 1008(1):40-8. PubMed ID: 15081380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity.
    Invernizzi R; Carli M; Di Clemente A; Samanin R
    J Neurochem; 1991 Jan; 56(1):243-7. PubMed ID: 1824782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the rat.
    Helke CJ; McDonald CH; Phillips ET
    J Auton Nerv Syst; 1993 Feb; 42(2):177-88. PubMed ID: 8450176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.